Background Left ventricular function is the main predictor of long-term survival in patients with coronary artery disease. In patients with impaired left ventricular function after myocardial infarction, end-systolic volume is a better predictor than the global ejection fraction. We analyzed long-term follow-up of patients with impaired left ventricular function undergoing coronary artery bypass graft surgery to evaluate preoperative predictors of survival.
In patients with impaired left ventricular function after myocardial infarction, end-systolic volume is a better predictor than the global ejection fraction. We analyzed long-term follow-up of patients with impaired left ventricular function undergoing coronary artery bypass graft surgery to evaluate preoperative predictors of survival.
Methods and Results Consecutive patients with ejection fractions <40% (n=193) who had undergone surgical revascularization were followed to assess the predictive value of preoperative baseline characteristics and catheterization findings for long-term survival. Patients were followed for 133+±30.7 months. At the time of surgery, patient age was 56±7.9 years and 169 patients (87.6%) had a history of previous myocardial infarction. Thirty-one patients (16%) were female. The ejection fraction was 32±7%, and the end-systolic volume was 147.4+52.6 mL. One hundred sixtyfour patients (84.9%) had three-vessel disease, and 44 (22.8%) had a left main stenosis with >50% diameter loss. Follow-up was complete in 99%. Fourteen patients died (7.3%) within the first 30 days after surgery. Twelve-month actuarial survival was 86%, 4-year survival was 80%, and 10-year survival was 40%. Predictors 
Results

Preoperative Features
The mean age of the patients was 56+7.9 years (range, 32 to 73 years). Eighty-four percent (n=162) were male. Baseline characteristics and cardiac catheterization findings are shown in Table 1 . Eighty-six percent of patients had angina of Canadian classification 3 or 4, whereas 24% were in New York Heart Association functional class III or IV. Eighty-eight percent of patients had a history of previous myocardial infarction (one in 38%, two in 37%, three in 10%, and four in 3%). Seven percent had infarction within 6 weeks before surgery.
The left ventricular ejection fraction was between 31% and 40% in 65% of patients, between 21% and 30% in 25%, and <20% in the remaining 10%. Endsystolic volume was <95 mL (normal ±3 SD) in 14.5% of patients, 95 to 130 mL in 29% of patients, and > 130 mL (normal +5 SD) in 56.5% of patients. Left ventricular end-diastolic pressure was raised (above 14 mm Hg) in 58% of patients.
More than 97% of patients had two-or three-vessel coronary artery disease. The myocardial score was > 10 in 89% and 5 to 10 in the remaining patients. Twentyfour percent of patients had an occlusion score of > 10, . At the time of review, only 1% of patients (n=2) were lost to long-term follow-up. Four percent of patients (n=8) had undergone a second coronary artery bypass graft operation. Two of these died later during follow-up. One patient received a heart transplant during follow-up and was censored at the time of transplantation. The figure shows the actuarial survival rate of the study group compared with that of a similar population matched for age and sex from the same geographic location in 1986 and 1987.7 Twelve-month actuarial survival was 86%, and 4-year survival was 80%. During this period, survival paralleled the general population with in-hospital mortality accounting for most of the difference. However, after 4 years the survival curve of the study group declined at a steeper, almost linear rate, with a 6-year survival rate of 65% compared with 89% in the normal population and a 10-year survival rate of 40% compared with 81% in the normal population. At Table 3) . End-systolic volume index was also the most powerful predictor of survival when only cardiac deaths were analyzed (P<.0001).
For patients with end-systolic volumes of 295 mL versus <95 mL, the risk ratio for mortality was 1.15 (confidence interval, 1.00 to 1.34) , and for patients with end-systolic volumes of >130 mL compared with .130 mL, the risk ratio was 1.51 (1.13 to 2.00). Other Factors The number of previous myocardial infarctions, preoperative stenosis score, and age were independent predictors of survival. Diabetes and diuretic use were 
Discussion
In this study, Cox regression analysis showed that in patients undergoing coronary surgery with impaired left ventricular function, end-systolic volume index, the number of previous myocardial infarctions, preoperative stenosis score, and age were independent predictors of long-term survival. End-systolic volume index was the strongest predictor.
Patient selection and surgical practices have changed since the patients in this study had surgery. Most had severe symptoms of angina (54% were in class IV and 32% were in class III). Most operative candidates were likely to have reasonable distal arteries for grafting, and few patients received internal mammary grafts. Techniques of myocardial protection have improved, and the use of antiplatelet therapy to reduce the incidence of vein graft closure has become more widespread. However, it is very likely that these results also apply to patients currently undergoing coronary artery bypass graft surgery.
Many studies have looked at risk factors for outcome after coronary artery bypass graft surgery and have found that the factor of greatest predictive value is left ventricular function measured as global ejection fraction.4 '8-12 Other factors identified as having independent effects on survival include previous myocardial infarction,9"11,13,14 age at the time of surgery,8-11,13,15 and severity of coronary artery disease.4'8-11,13,15 Diabetes,8'10'12"3 hypertension,8'9"3 diuretic therapy,"1",3"14 smoking,9"1' raised cholesterol,9 and other concomitant diseases813 have often, but not consistently, been found to have an independent adverse longterm effect on survival.
A number of studies have found previous infarction to be an adverse prognostic factor after myocardial infarction. [16] [17] [18] It is surprising that a history of previous myocardial infarction is an independent prognostic factor when the degree of left ventricular damage is already reflected in the measurement of ejection fraction or end-systolic volume. However, patients who have already sustained a myocardial infarction have declared themselves as having a propensity for plaque rupture and consequent coronary thrombosis and are at high risk of further infarction in a different infarct zone19 and death.
In some studies, female gender has been found to be associated with an increased risk of early surgical mortality.20-22 However, when corrected for physical size, sex may not be a risk factor.23 In a few studies,8"1024 female gender has been found to adversely affect longterm survival, whereas others have not confirmed gender as an important prognostic factor.12 '25'26 In a previous study from our institution, predictors of late death were evaluated in all patients undergoing coronary artery bypass graft surgery during 1976 and 1977.27 Predictors of late death were low ejection fraction, number of preoperative myocardial infarctions, prior cardiac surgery, increased cardiothoracic ratio, and the number of coronary arteries with significant stenoses. End-systolic volume was not found to be an independent risk factor. However, only 30% of patients had impaired left ventricular function with an ejection '36 In the Survival and Ventricular Enlargement (SAVE) trial, patients with ejection fractions <40% but without overt heart failure were randomized to captopril or placebo within 3 to 16 days after myocardial infarction.37 Over a 4-year follow-up, there was a 19% (3% to 25%, P=.019) lower mortality from all causes in the treatment group than in the placebo group. The incidence of development of severe heart failure was reduced by 37% (20% to 50%, P<.001). In the SOLVD prevention trial, asymptomatic patients with ejection fractions of .35% were randomized to enalapril or placebo for an average of 3 years. There was a significant reduction in the incidence of heart failure (29% risk reduction, P<.001), reduction in hospitalization for heart failure (20% risk reduction, P<.001), and a trend toward reduction in cardiovascular mortality (P=.12). 38 Patients with left ventricular systolic dysfunction continue to develop progressive dilatation over time remote from the time of their infarction.34'39 The remodeling process may be slowed or reversed by ACE inhibitor therapy even if begun late after the initial infarction.34 '39 In a subgroup of 56 patients from the SOLVD prevention trial, enalapril decreased end-systolic volume after 1 year of treatment compared with placebo by 23 mL/m2 (P<.005) and also improved diastolic function as measured by left ventricular relaxation time.39 Diastolic dysfunction and the nonuniform progression of regional remodeling were also prevented by long-term enalapril treatment in another substudy from the SOLVD investigators involving 28 patients from their prevention study (ejection fraction .35% not requiring therapy for heart failure) and 8 from their treatment study. It has also recently been shown that ACE inhibitor therapy may reduce the incidence of reinfarction.37 '40 There is a lack of randomized studies regarding the use of ACE inhibition over the time of coronary artery surgery. The SOLVD treatment and prevention studies3841 and the SAVE study37 avoided recruiting patients before cardiac surgery. However, a study of short-term treatment with captopril versus placebo before cardiac surgery found no difference in blood pressure or fluid requirements during the operative period fraction <50%.
and a higher glomerular filtration rate in the captopril-treated group. 42 The present study of patients who had surgery between 1972 and 1981 allows evaluation of end-systolic volume as a predictor of survival before the general availability and use of ACE inhibitors.
Coronary artery bypass graft surgery has been shown to improve survival in patients with impaired left ventricular function. [43] [44] [45] In the CASS study, 160 patients had ejection fractions between 35% and 50% and were randomized to medical therapy or to surgery. In patients with three-vessel disease, survival at 7 years was 88% in the surgically treated group compared with 65% in the medically treated group (p<.01).42 Data from the CASS registry showed that patients with ejection fractions <26% had a 5-year survival of 63% with surgery versus 43% with medical treatment (P<.01). Also, a subgroup analysis of the Veterans Administration study showed improved survival with surgery in patients with impaired left ventricular function and three-vessel coronary artery disease.45 It therefore cannot be assumed that other therapies believed to benefit patients with impaired left ventricular function will necessarily also improve prognosis after coronary bypass graft surgery. A study randomizing patients with impaired left ventricular function undergoing coronary bypass graft surgery to ACE inhibitors or placebo is required.
We conclude that left ventricular end-systolic volume is the most important factor predicting survival in patients with impaired left ventricular function undergoing coronary artery bypass graft surgery. Further information is required as to whether therapies such as ACE inhibitors may improve long-term outcome.
